Similar articles for PMID: 33608471

Year	Number of Results
2009	1
2012	1
2013	1
2014	8
2015	5
2016	13
2017	15
2018	16
2019	20
2020	12
2021	5
2025	0

1

Statistically Significant versus Practically Relevant Trend in Stability Data.

Schmelzer B, Mischo A, Innerbichler F. Schmelzer B, et al. PDA J Pharm Sci Technol. 2021 Jul-Aug;75(4):341-356. doi: 10.5731/pdajpst.2020.012336. Epub 2021 Feb 19. PDA J Pharm Sci Technol. 2021. PMID: 33608471

2

Evolution of the EU Biosimilar Framework: Past and Future.

Wolff-Holz E, Tiitso K, Vleminckx C, Weise M. Wolff-Holz E, et al. BioDrugs. 2019 Dec;33(6):621-634. doi: 10.1007/s40259-019-00377-y. BioDrugs. 2019. PMID: 31541400 Free PMC article. Review.

3

On Statistical Approaches for Demonstrating Analytical Similarity in the Presence of Correlation.

Yang H, Novick S, Burdick RK. Yang H, et al. PDA J Pharm Sci Technol. 2016 11/12;70(6):547-559. doi: 10.5731/pdajpst.2016.006551. Epub 2016 Jun 20. PDA J Pharm Sci Technol. 2016. PMID: 27325594

4

CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.

Newsome SD, Aliotta PJ, Bainbridge J, Bennett SE, Cutter G, Fenton K, Lublin F, Northrop D, Rintell D, Walker BD, Weigel M, Zackowski K, Jones DE. Newsome SD, et al. Int J MS Care. 2016 Nov-Dec;18(6):314-323. doi: 10.7224/1537-2073.2016-051. Int J MS Care. 2016. PMID: 27999526 Free PMC article.

5

Statistical Considerations on Clinical Efficacy Studies of Biosimilar for PMDA Submission.

Asami Y, Pan J, Oh M, Sato A. Asami Y, et al. Ther Innov Regul Sci. 2020 Sep;54(5):1134-1137. doi: 10.1007/s43441-020-00133-3. Epub 2020 Mar 3. Ther Innov Regul Sci. 2020. PMID: 32128700

6

Adjustment for unbalanced sample size for analytical biosimilar equivalence assessment.

Dong XC, Weng YT, Tsong Y. Dong XC, et al. J Biopharm Stat. 2017;27(2):220-232. doi: 10.1080/10543406.2016.1265544. Epub 2017 Jan 6. J Biopharm Stat. 2017. PMID: 28060570

7

Krause S, Lacana E, Welch J, Shapiro M, Downey C, Chung J, Zhou Q, Van Der Plas M, Depatie C, Ingram B, Srebalus-Barnes C, Polozova A, Rellahan B, Choi D, Burdick R, Stangler T, Shacter E. Krause S, et al. PDA J Pharm Sci Technol. 2019 Jul-Aug;73(4):401-416. doi: 10.5731/pdajpst.2019.010215. Epub 2019 Apr 19. PDA J Pharm Sci Technol. 2019. PMID: 31004040

8

Sample size requirement in analytical studies for similarity assessment.

Chow SC, Song F, Bai H. Chow SC, et al. J Biopharm Stat. 2017;27(2):233-238. doi: 10.1080/10543406.2016.1265545. Epub 2016 Dec 9. J Biopharm Stat. 2017. PMID: 27935446

9

Scientific considerations for assessing biosimilar products.

Chow SC, Wang J, Endrenyi L, Lachenbruch PA. Chow SC, et al. Stat Med. 2013 Feb 10;32(3):370-81. doi: 10.1002/sim.5571. Epub 2012 Aug 30. Stat Med. 2013. PMID: 22933240

10

On sample size requirement for analytical similarity assessment.

Zhao Y, Chang YW, Chow SC. Zhao Y, et al. J Biopharm Stat. 2018;28(6):1143-1159. doi: 10.1080/10543406.2018.1437171. Epub 2018 Mar 7. J Biopharm Stat. 2018. PMID: 29513612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 33608471

83 results

Results by year